[go: up one dir, main page]

FI20040180L - Koostumus psoriasis-taudin hoitamiseksi - Google Patents

Koostumus psoriasis-taudin hoitamiseksi Download PDF

Info

Publication number
FI20040180L
FI20040180L FI20040180A FI20040180A FI20040180L FI 20040180 L FI20040180 L FI 20040180L FI 20040180 A FI20040180 A FI 20040180A FI 20040180 A FI20040180 A FI 20040180A FI 20040180 L FI20040180 L FI 20040180L
Authority
FI
Finland
Prior art keywords
psoriasis
treatment
composition
Prior art date
Application number
FI20040180A
Other languages
English (en)
Swedish (sv)
Other versions
FI20040180A0 (fi
FI121915B (fi
Inventor
Thomas Tallberg
Original Assignee
Helsingfors Institution Foer B
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helsingfors Institution Foer B filed Critical Helsingfors Institution Foer B
Publication of FI20040180A0 publication Critical patent/FI20040180A0/fi
Priority to FI20040180A priority Critical patent/FI121915B/fi
Priority to DK05708155.6T priority patent/DK1718290T3/da
Priority to PCT/FI2005/000075 priority patent/WO2005074910A1/en
Priority to RU2006128209/15A priority patent/RU2372899C2/ru
Priority to PL05708155T priority patent/PL1718290T3/pl
Priority to ES05708155T priority patent/ES2344510T3/es
Priority to AU2005210181A priority patent/AU2005210181B2/en
Priority to PT05708155T priority patent/PT1718290E/pt
Priority to CA2555328A priority patent/CA2555328C/en
Priority to AT05708155T priority patent/ATE466576T1/de
Priority to DE602005021062T priority patent/DE602005021062D1/de
Priority to BRPI0507732-0A priority patent/BRPI0507732A/pt
Priority to JP2006551868A priority patent/JP4919812B2/ja
Priority to US10/588,051 priority patent/US20070258892A1/en
Priority to HK07103397.6A priority patent/HK1097455B/en
Priority to CN2005800041621A priority patent/CN1917868B/zh
Priority to EP05708155A priority patent/EP1718290B1/en
Publication of FI20040180L publication Critical patent/FI20040180L/fi
Priority to NO20063937A priority patent/NO20063937L/no
Application granted granted Critical
Publication of FI121915B publication Critical patent/FI121915B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI20040180A 2004-02-06 2004-02-06 Koostumus psoriasiksen hoitoon FI121915B (fi)

Priority Applications (18)

Application Number Priority Date Filing Date Title
FI20040180A FI121915B (fi) 2004-02-06 2004-02-06 Koostumus psoriasiksen hoitoon
CA2555328A CA2555328C (en) 2004-02-06 2005-02-04 Composition, comprising l-serine, l-isoleucine, folic acid and trace elements, for treating psoriasis
DE602005021062T DE602005021062D1 (de) 2004-02-06 2005-02-04 Zusammensetzung mit l-serin, l-isoleucin, folsäure und spurenelementen zur behandlung von psoriasis
RU2006128209/15A RU2372899C2 (ru) 2004-02-06 2005-02-04 Фармацевтическая композиция для лечения псориаза, содержащая l-серин, l-изолейцин, фолиевую кислоту и микроэлементы
PL05708155T PL1718290T3 (pl) 2004-02-06 2005-02-04 Kompozycja do leczenia łuszczycy zawierająca L-serynę, L-izoleucynę, kwas foliowy i pierwiastki śladowe
ES05708155T ES2344510T3 (es) 2004-02-06 2005-02-04 Composicion que comprende l-serina, l-isoleucina, acido folico y elementos traza, para tratar la psoriasis.
AU2005210181A AU2005210181B2 (en) 2004-02-06 2005-02-04 Composition, comprising L-serine, L-isoleucine, folic acid and trace elements, for treating psoriasis
PT05708155T PT1718290E (pt) 2004-02-06 2005-02-04 COMPOSIÆO, INCLUINDO L-SERINA, L-ISOLEUCINA, áCIDO FËLICO E OLIGOELEMENTOS, PARA TRATAR A PSORASE
DK05708155.6T DK1718290T3 (da) 2004-02-06 2005-02-04 Sammensætning, som omfatter L-serin, L-isoleucin, folinsyre og sporelementer, til behandling af psoriasis
AT05708155T ATE466576T1 (de) 2004-02-06 2005-02-04 Zusammensetzung mit l-serin, l-isoleucin, folsäure und spurenelementen zur behandlung von psoriasis
PCT/FI2005/000075 WO2005074910A1 (en) 2004-02-06 2005-02-04 Composition, comprising l-serine, l-isoleucine, folic acid and trace elements, for treating psoriasis
BRPI0507732-0A BRPI0507732A (pt) 2004-02-06 2005-02-04 composição compreendendo l-serina, l-isoleucina, ácido fólico e micro elementos para tratamento da psorìase e uso desta
JP2006551868A JP4919812B2 (ja) 2004-02-06 2005-02-04 Ｌ−セリン、ｌ−イソロイシン、葉酸及び微量元素を含む乾癬を治療するための組成物
US10/588,051 US20070258892A1 (en) 2004-02-06 2005-02-04 Composition, Comprising L-Serine, L-Isoleucine, Folic Acid and Trace Elements, for Treating Psoriasis
HK07103397.6A HK1097455B (en) 2004-02-06 2005-02-04 Composition, comprising l-serine, l-isoleucine, folic acid and trace elements, for treating psoriasis
CN2005800041621A CN1917868B (zh) 2004-02-06 2005-02-04 包含l-丝氨酸、l-异亮氨酸、叶酸和痕量元素的用于治疗银屑病的组合物
EP05708155A EP1718290B1 (en) 2004-02-06 2005-02-04 Composition, comprising l-serine, l-isoleucine, folic acid and trace elements, for treating psoriasis
NO20063937A NO20063937L (no) 2004-02-06 2006-09-04 Sammensetning omfattende L-serin, L-isoleucin, folsyre og sporelementer for behandling av psoriasis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20040180A FI121915B (fi) 2004-02-06 2004-02-06 Koostumus psoriasiksen hoitoon
FI20040180 2004-02-06

Publications (3)

Publication Number Publication Date
FI20040180A0 FI20040180A0 (fi) 2004-02-06
FI20040180L true FI20040180L (fi) 2005-08-07
FI121915B FI121915B (fi) 2011-06-15

Family

ID=31725662

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20040180A FI121915B (fi) 2004-02-06 2004-02-06 Koostumus psoriasiksen hoitoon

Country Status (17)

Country Link
US (1) US20070258892A1 (fi)
EP (1) EP1718290B1 (fi)
JP (1) JP4919812B2 (fi)
CN (1) CN1917868B (fi)
AT (1) ATE466576T1 (fi)
AU (1) AU2005210181B2 (fi)
BR (1) BRPI0507732A (fi)
CA (1) CA2555328C (fi)
DE (1) DE602005021062D1 (fi)
DK (1) DK1718290T3 (fi)
ES (1) ES2344510T3 (fi)
FI (1) FI121915B (fi)
NO (1) NO20063937L (fi)
PL (1) PL1718290T3 (fi)
PT (1) PT1718290E (fi)
RU (1) RU2372899C2 (fi)
WO (1) WO2005074910A1 (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI122450B (fi) * 2007-12-28 2012-01-31 Neurofood Ab Oy Koostumus steriilin inflammaation hoitoon
FR2947452B1 (fr) * 2009-07-01 2012-04-20 Fabre Pierre Dermo Cosmetique L-serine et/ou l-asparagine et/ou l-valine pour prevenir et/ou au traiter des reactions inflammatoires de la peau.
CN101953846B (zh) * 2010-06-24 2011-12-28 攀枝花兴辰钒钛有限公司 一种药物组合物在制备治疗糖尿病的药物中的用途
DK2782566T3 (da) * 2011-11-21 2021-02-08 The Inst For Ethnomedicine L-serin til anvendelse ved behandling af neurodegenerative lidelser
EP3586849A1 (en) * 2018-06-29 2020-01-01 Aprofol AG Folate preparations
WO2021035060A1 (en) * 2019-08-21 2021-02-25 Brain Chemistry Labs Compositions comprising a metal and l-serine, and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83775A (en) * 1987-09-04 1991-12-15 Dexter Chemical Corp Amino acid esters and amides of fumaric acid and pharmaceutical compositions containing them for use in the treatment of psoriasis
DE3712986A1 (de) * 1987-04-16 1988-10-27 Marbert Gmbh Medizinische zubereitungen auf der grundlage von biertreberextrakt, verfahren zu deren herstellung sowie verwendung von biertreberextrakt zur herstellung von kosmetischen zubereitungen und ein spezieller biertreberextrakt
US5326569A (en) * 1992-12-23 1994-07-05 Abbott Laboratories Medical foods for the nutritional support of child/adult metabolic diseases
CN1080131A (zh) * 1993-04-28 1994-01-05 王韵三 一种美容保健营养食品和制备方法
US5563132A (en) * 1994-06-21 1996-10-08 Bodaness; Richard S. Two-step cancer treatment method
RU2071777C1 (ru) * 1995-01-13 1997-01-20 Тамара Васильевна Воробьева Способ получения средства, обладающего противоопухолевой активностью
US6083293A (en) * 1997-02-24 2000-07-04 Bath; Virginia L. Method for enhanced plant protein production and composition for use in the same
IT1299623B1 (it) * 1998-02-23 2000-03-24 Gen Topics Srl Composizione per uso cosmetico o farmaceutico a base di acido lipoico e acido piruvico
WO1999055321A1 (en) * 1998-04-24 1999-11-04 Mitokor Compounds and methods for treating mitochondria-associated diseases
GB0019327D0 (en) * 2000-08-08 2000-09-27 Buchanan Baillie Hamilton Paul Slimming system
US20040086583A1 (en) * 2002-11-01 2004-05-06 Jensen Claude Jarakae Anti-angiogenesis effects of morinda citrifolia

Also Published As

Publication number Publication date
FI20040180A0 (fi) 2004-02-06
DE602005021062D1 (de) 2010-06-17
CN1917868B (zh) 2010-09-01
RU2372899C2 (ru) 2009-11-20
ES2344510T3 (es) 2010-08-30
DK1718290T3 (da) 2010-08-02
FI121915B (fi) 2011-06-15
CN1917868A (zh) 2007-02-21
PL1718290T3 (pl) 2010-10-29
BRPI0507732A (pt) 2007-07-10
CA2555328C (en) 2013-03-26
AU2005210181B2 (en) 2010-05-20
HK1097455A1 (en) 2007-06-29
ATE466576T1 (de) 2010-05-15
EP1718290B1 (en) 2010-05-05
NO20063937L (no) 2006-09-04
JP4919812B2 (ja) 2012-04-18
JP2007520532A (ja) 2007-07-26
EP1718290A1 (en) 2006-11-08
WO2005074910A1 (en) 2005-08-18
PT1718290E (pt) 2010-07-01
US20070258892A1 (en) 2007-11-08
AU2005210181A1 (en) 2005-08-18
CA2555328A1 (en) 2005-08-18
RU2006128209A (ru) 2008-03-20

Similar Documents

Publication Publication Date Title
LT2478907T (lt) Kompozicijos vėžiui gydyti
NO20070251A (no) Brønnbehandling
NO20070297A (no) Brønnbehandling
DE602005015234D1 (de) Zusammensetzungen zur wäschebehandlung
DE602005014252D1 (de) Zusammensetzungen zur wäschebehandlung
CY2016017I2 (el) Συνθεση για θεραπεια πνευμονικης υπερτασης
PT2056814E (pt) Compostos de 2,5-di-hidroxibenzeno para o tratamento da psoríase
DK1868579T3 (da) Farmaceutisk sammensætning omfattende en omega-carboxyaryl sunstitueret diphenylurea til behandling af cancer
DE602005023172D1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
DK1685834T3 (da) Anvendelse af pinolensyre til behandling af obesitet
CY2018006I1 (el) Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
PL2205720T3 (pl) Kompozycja do leczenia stwardnienia rozsianego
DK3403657T3 (da) Anvendelse af oligouronater til behandling af slimhyperviskositet
EP1863899A4 (en) COMPOSITIONS FOR TREATING SKIN
FI20095600L (fi) Koostumus ihosairauksien hoitoa varten
HRP20150320T1 (xx) Formulacije i metode za lijeäśenje amiloidoze
EP1810994A4 (en) CURABLE PREPARATION
PT1763520E (pt) Utilização de benzopiranonas trissubstituídas
DK1709082T3 (da) Sammensætning til behandling af patologi knyttet til MSRV/HERV-W
ITRM20050179A1 (it) Composizione impiegabile per il trattamento delle patologie paradontali.
FI20040180L (fi) Koostumus psoriasis-taudin hoitamiseksi
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
EP1946163A4 (en) MANUFACTURE OF NANOWIL
DE602004011679D1 (de) Behandelung von Störungen
DK1940447T3 (da) Behandling af neurodegenrative lidelser

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: OY NEUROFOOD AB

Free format text: OY NEUROFOOD AB

FG Patent granted

Ref document number: 121915

Country of ref document: FI

MM Patent lapsed